Previous 10 | Next 10 |
Zynex Schedules 2021 Third Quarter Earnings Call PR Newswire ENGLEWOOD, Colo., Oct. 25, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pai...
Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate PR Newswire ENGLEWOOD, Colo. , Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-in...
Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference PR Newswire ENGLEWOOD, Colo. , Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing ...
Zynex faces at least 12 contentious issues that reveal troubling fundamentals. The business model is not sustainable for the long term. The shares are grossly overvalued based on DCF, Discount EPS, and Reverse DCF and Reverse EPS valuation models. Until ethical concerns and th...
Public health officers have been focused on Covid-19 for the last 18 months and all other public health issues have taken a back seat to Covid-19 response efforts. Opioid overdoses have increased during the pandemic. Zynex has seen rapid growth in revenues and earnings but the sto...
Gainers: ERYTECH Pharma (NASDAQ:ERYP) +64%. Allied Healthcare Products (NASDAQ:AHPI) +49%. iFresh (NASDAQ:IFMK) +35%. Marin Software Incorporated (NASDAQ:MRIN) +29%. Atlassian Corporation (NASDAQ:TEAM) +24%. Xiaobai Maimai (NASDAQ:HX) +18%. First High-School Education (NYSE:FHS) +16%. Bridgel...
Image source: The Motley Fool. Zynex, inc (NASDAQ: ZYXI) Q2 2021 Earnings Call Jul 29, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, inc (ZYXI) Q2 2021 Earnings Call Transcript
Zynex, Inc. (ZYXI) Q2 2021 Results Conference Call July 29, 2021 04:15 PM ET Company Participants Thomas Sandgaard - President and Chief Executive Officer Daniel Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright Marc Wie...
Zynex (NASDAQ:ZYXI): Q2 GAAP EPS of $0.08 beats by $0.01. Revenue of $31M (+61.0% Y/Y) misses by $0.26M. Adjusted EBITDA was $4.8 million Shares -1.4%. Press Release For further details see: Zynex EPS beats by $0.01, misses on revenue
Zynex Announces 2021 Second Quarter Earnings PR Newswire ENGLEWOOD, Colo. , July 29, 2021 /PRNewswire/ -- 2021 Second Quarter Revenue increased 61% year over year to $31.0 million Orders increased 247% Net income ...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...